Advertisement Cubist expands R&D facility in US - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cubist expands R&D facility in US

Cubist Pharmaceuticals has opened expanded research and development facility at its headquarters in Massachusetts, US.

The 104,000ft² expansion majorly includes laboratory space for research and development around antibiotics and other acute care products and a molecular modeling room.

Built to the LEED Silver Standard, the building features high efficiency plumbing and lighting fixtures, distribution controlled heating and cooling systems, and updated mechanical equipment and Energy Star-rated appliances.

Cubist president and CEO Michael Bonney said the company looks forward to translate exciting science into real therapeutic options for patients in the acute care and hospital environment.